pembrolizumab,eftilagimod
novartis,merck
['pembro', 'eftilagimod']
eftilagimod alpha plus pembrolizumab generates responses, safety in metastatic hnscc #asco23 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.